Why do we need 2 samples? The aspirate allows us to individually look at each BM cell under the microscope π¬ (e.g. WBCs, RBCs) and classify them via flow cytometry (a method of identifying and measuring pathological cells using their surface markers e.g. CD19 for B-cells)
The trephine lets us look at the way the BM is organised and assess for things like fibrosis and infiltration. We can also apply stains π (immunohistochemistry) to detect specific cells on the trephine
How is it done? It is a quick (20-30 min) awake procedure using local anaesthetic. It does not require a theatre and is often done at the patient bedside. It is done aseptically using 2 separate needles π (aspirate and trephine).
Where do you take the samples from? Most times we manage to get samples from the posterior iliac crest (on either side). If this is not possible (e.g. mobility issues), we can also access the anterior iliac crest. In rare cases, we may also consider accessing the sternum
Does it hurt? Highly variable! We always try to make it as comfortable as possible with local anaesthetic. Some find it painful, some uncomfortable, some don't feel it at all! For people who need frequent BMBs (e.g. patients w/ acute leukaemia), they often get "easier" over time.
Can you do it with low platelets or if the patient is on anticoagulants/antiplatelets? Yes. BMBs do not tend to cause significant bleeding, and usually this can be stopped with mechanical measures i.e. pressure
Are there any complications? BMB is a very safe procedure. Complications are usually limited to pain/discomfort, and a small risk of bleeding and infection. Damage to surrounding structures (e.g. nerves and blood vessels) is extremely rare.
How long do results take? β± An aspirate can be processed fairly quickly depending on urgency - sometimes within 24 hours. A trephine can take a bit longer (around 5 days) as it needs to be decalcified and then stained. Special stains (IHC) take longer.
In summary,Β BMB can be a really helpful test in specific situations and it's safe and generally well tolerated. Let us know if you have any questions - and next time your friendly haematologist is on your ward performing one, go along and see for yourself!π€ #FOAMed#blooducation
β’ β’ β’
Missing some Tweet in this thread? You can try to
force a refresh
Quick tip; A prolonged APTT is more likely to indicate an underlying factor deficiency than a prolonged PT
BUT factor deficiency is not the most common cause for a prolonged APTT
2/ The most common causes include
- Heparin (either circulating in blood or in the line the sample was taken from)
- Lupus anticoagulant
- Liver disease (expect prolonged PT also)
- DIC (expect prolonged PT and low fibrinogen also)
- Factor deficiencies
3/ The coagulation factors associated with the APTT test are;
Is supported by data from the PLADO study + others (see refs) which show that giving more than a standard dose of platelets (1 pool/unit* in an adult) did not β¬οΈ bleeding incidence
2/ Each platelet exposure has (uncommon but significant) risks of allergic reaction, virus transmission and...
Each exposure to platelets is also another potential exposure to HLA antigens which the recipient does not have
3/ This may not have a big impact for many patients but for those awaiting transplants (haem or solid organ @BukuRenal) it increases the chance of graft rejection.
1/ Neutropenic sepsis tweetorial
Β
Febrile neutropenia is a common and serious complication of chemotherapy treatment and can rapidly progress to life-threatening severe sepsis. Patients with bone marrow failure conditions (e.g. AML, Myelodysplastic syndrome) are also at risk.
2/ Outcomes have improved with increased recognition of the importance of prompt treatment and better supportive care, driven by initiatives such as the Surviving Sepsis Campaign.
π₯IV antibiotics must be given within one hour in all suspected neutropenic sepsis π₯
3/ Patient education is crucial, as is a failsafe, 24/7 contact line for prompt assessment and treatment in secondary care: once there, antimicrobials should be given within the hour.
π¬History, examination, imaging and cultures are then used to pinpoint the source.
1/ Tweetorial: DOACs in cancer
Β
The risk of venous thromboembolism (VTE) is up to 7 x higher in patients with cancer, and contributes to morbidity and mortality
Overall prognosis is worse in patients with cancer and VTE, compared to those with cancer and no VTE
2/ The treatment of VTE in cancer is complex due to concerns around;
3/ LMWH was traditionally the treatment of choice, with data from the CLOT study (2003) showing improved efficacy vs warfarin & no β¬οΈ bleeding risk
It is a useful option as no monitoring (usually) required, less interactions and short T1/2. It is however given by injection...
1/ Antidote news! There has been promise recently regarding antidotes being developed for DOACs. Before we get onto that, a quick summary of what we have so far...
2/ In the case of bleeding while on warfarin, this should be stratified by severity. Usual rule is if life/limb/sight threatening bleeding, prothrombin complex concentrate + vit K is used. If not, vitamin K +- pause/cessation of warfarin is advised.
3/ Warfarin works by inhibiting vitamin K-dependent clotting factor production. These factors are II, VII, IX and X. The 'antidote' is prothrombin complex concentrate (e.g beriplex) which is a concentrated 'soup' of factors II, VII, IX and X (and some protein C and S)
1/19. When considering whether a patient is at risk of bleeding before a procedure/surgery or if a patient is bleeding and you want to assess if there are any 'correctable' clotting abnormalities, a thorough approach is needed to ensure all factors are identified.
2/19. The patient might have a PT of 19 seconds but this will probably make little/no difference in terms of bleeding risk, but the clopidogrel they have continued to take without telling the nurses/medical staff really will. I.e the coagulation screen isn't the whole picture..
3/19. The 3 main elements are platelets, fibrinogen and clotting factors.
Platelet function depends on platelet number and function. Count can be reduced by many causes. Major surgery can occur with a platelet count of 50x10^9 or more (BSH guidelines. Note neurosurgery >100)